ATTD: Advanced Technologies and Treatments for Diabetes

In this episode, host Bob Gabbay and his guest, Diana Isaacs PharmD, break down common barriers to insulin adherence; from the common reasons people may struggle with insulin, to behaviour change approaches that can help clinicians support their patients.
They discuss:
The barriers most misunderstood by clinicians

Communication and motivational interviewing with patients

Emotional burden and fear of hypoglycemia

Practical strategies clinicians can use to support patients more effectively

The role of the wider diabetes healthcare team

Diana Isaacs is an Endocrine Clinical Pharmacist and Director of Education and Training in Diabetes Technology at the Cleveland Clinic.
Explore more on the ATTD Education Portal. Register now to access exclusive content and stay ahead in the field!
Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.

In this episode, host Bob Gabbay and his guest, Professor Simon Heller, discuss preventing and managing hypoglycemia, with a focus on the risks, recognition, and safety education.
They discuss:
Why hypoglycemia remains a major concern in insulin therapy

Key risk factors to keep in mind

Clinical signs or patient-reported symptoms

Prevention strategies

Importance of patient education

Balancing glycemic targets with hypoglycemia risk

Prof. Simon Heller is Professor of Clinical Diabetes at the University of Sheffield, and Director of Research & Development at Sheffield Teaching Hospitals, NHS Foundation Trust.
Explore more on the ATTD Education Portal. Register now to access exclusive content and stay ahead in the field!
Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.

In this episode, host Bob Gabbay and his guest, Professor Tadej Battelino, Co-Chair of ATTD, discuss the latest technological innovations in diabetes, including delivery innovations, connected devices, titration support.
They discuss:
The new technologies making the biggest difference in insulin therapy today

The role of smart pens, connected devices, and apps

Biggest clinical impact - including adherence, titration and outcomes

Accessibility of these tools in real-world practice

Advisor role of AI

The promising future of technology in insulin therapy and a functional cure

Professor Tadej Battelino is Co-Chair of ATTD and Chair of International Diabetes Federation Europe.
Explore more on the ATTD Education Portal. Register now to access exclusive content and stay ahead in the field!
Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.

In this episode, host Bob Gabbay and his guest, Dr George Grunberger, Chairman of the Grunberger Diabetes Institute, discuss best practice and guidance around basal insulin and GLP-1 combinations.
They discuss:
What exactly fixed-ratio combinations are and the problems they tackle

Identifying patient candidates and timelines for starting FRCs

Meaningful benefits of FRCs compared with basal insulin alone

Concerns and limitations of FRCs

How guideline recommendations currently position FRCs in diabetes management

Dr George Grunberger, Chairman of the Grunberger Diabetes Institute in Michigan. George is also Clinical Professor of Internal Medicine at Wayne State University School of Medicine, and Professor of Internal Medicine at Oakland University William Beaumont School of Medicine.
Explore more on the ATTD Education Portal. Register now to access exclusive content and stay ahead in the field!
Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.

In this episode, host Bob Gabbay and his guest, Dr William Polonsky discuss safe and effective titration strategies, and the importance of collaborating with your patient.
They discuss:
The importance of titration in successful insulin therapy

Barriers to titration, including patient self-management

How clinicians can collaborate with patients in their titration journey

The importance of language used by clinicians

Practical tips for simplifying titration in busy clinical settings

Dr. Polonsky is President and Founder of the Behavioral Diabetes Institute, and Associate Clinical Professor in Psychiatry at the University of California.
Explore more on the ATTD Education Portal. Register now to access exclusive content and stay ahead in the field!
Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.